ZA200509756B - Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith - Google Patents

Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith

Info

Publication number
ZA200509756B
ZA200509756B ZA200509756A ZA200509756A ZA200509756B ZA 200509756 B ZA200509756 B ZA 200509756B ZA 200509756 A ZA200509756 A ZA 200509756A ZA 200509756 A ZA200509756 A ZA 200509756A ZA 200509756 B ZA200509756 B ZA 200509756B
Authority
ZA
South Africa
Prior art keywords
treatment
methods
stem cells
hematopoietic stem
eye diseases
Prior art date
Application number
ZA200509756A
Other languages
English (en)
Inventor
Friedlander Martin
Dasilva Karen
Otani Atsushi
Hanekamp Stacey
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Publication of ZA200509756B publication Critical patent/ZA200509756B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • C12N5/0692—Stem cells; Progenitor cells; Precursor cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA200509756A 2003-05-02 2005-12-01 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith ZA200509756B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46705103P 2003-05-02 2003-05-02

Publications (1)

Publication Number Publication Date
ZA200509756B true ZA200509756B (en) 2006-10-25

Family

ID=36908146

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA200509756A ZA200509756B (en) 2003-05-02 2005-12-01 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
ZA200509752A ZA200509752B (en) 2003-05-02 2005-12-01 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA200509752A ZA200509752B (en) 2003-05-02 2005-12-01 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith

Country Status (10)

Country Link
EP (2) EP1754783A1 (xx)
JP (2) JP4714682B2 (xx)
KR (3) KR101169261B1 (xx)
CN (2) CN1831119B (xx)
AU (2) AU2004237749B2 (xx)
BR (1) BRPI0409861A (xx)
CA (2) CA2526670C (xx)
MX (2) MXPA05011752A (xx)
RU (2) RU2345780C2 (xx)
ZA (2) ZA200509756B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2554662A1 (en) * 2011-08-05 2013-02-06 M Maria Pia Cosma Methods of treatment of retinal degeneration diseases
AU2012321102C1 (en) 2011-10-27 2016-11-10 Pharma Cinq, Llc Vectors encoding rod-derived cone viability factor
RU2495650C1 (ru) * 2012-02-29 2013-10-20 Федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения и социального развития Российской Федерации Трехкомпонентный комплекс для клеточной терапии в офтальмологии
RU2485922C1 (ru) * 2012-03-28 2013-06-27 Федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения и социального развития Российской Федерации Способ лечения "сухой" формы возрастной макулярной дегенерации
CN107043699B (zh) * 2017-04-25 2023-04-07 徐子雁 一种低能量激光诱导间充质干细胞血管化的试剂盒

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002033043A2 (en) * 2000-10-18 2002-04-25 Coriell Institute For Medical Research Method and marker for the isolation of human multipotent hematopoietic stem cells
CN1307300C (zh) * 2002-07-25 2007-03-28 斯克里普斯研究学院 造血干细胞和治疗新生血管性眼部疾病的方法

Also Published As

Publication number Publication date
BRPI0409861A (pt) 2006-05-16
EP1624758A4 (en) 2007-03-07
RU2389497C2 (ru) 2010-05-20
KR101169261B1 (ko) 2012-08-03
AU2005239702B2 (en) 2010-03-04
JP2006525806A (ja) 2006-11-16
EP1754783A1 (en) 2007-02-21
RU2005137569A (ru) 2006-06-10
CN100439493C (zh) 2008-12-03
JP4714580B2 (ja) 2011-06-29
AU2004237749A1 (en) 2004-11-18
JP2006166918A (ja) 2006-06-29
CA2526670A1 (en) 2004-11-18
CN1831119B (zh) 2010-05-26
EP1624758A2 (en) 2006-02-15
CA2526670C (en) 2011-06-14
MXPA05011750A (es) 2006-06-06
JP4714682B2 (ja) 2011-06-29
KR101224375B1 (ko) 2013-01-21
ZA200509752B (en) 2006-11-29
RU2006103574A (ru) 2007-08-20
RU2345780C2 (ru) 2009-02-10
KR20120034251A (ko) 2012-04-10
CN1831119A (zh) 2006-09-13
CA2524063A1 (en) 2004-11-18
MXPA05011752A (es) 2006-06-06
AU2005239702A1 (en) 2005-12-22
KR20060008968A (ko) 2006-01-27
CA2524063C (en) 2015-02-17
AU2004237749B2 (en) 2011-09-15
CN1816281A (zh) 2006-08-09
KR20060056420A (ko) 2006-05-24

Similar Documents

Publication Publication Date Title
EP1562636A4 (en) MESENCHYMAL STEM CELLS AND METHODS OF USE
EP1581169A4 (en) COMPOSITIONS AND METHODS FOR TREATING DISEASES RELATED TO NATURAL K CELLS
IL157364A0 (en) Therapeutic methods and agents for diseases associated with decreased expression of aop-1 gene or aop-1
EP1701654A4 (en) IMPLANTABLE BIOSPER AND METHODS OF USING SAME
IL180739A0 (en) Novel fenofibrate formulations and related methods of treatment
EP1718732A4 (en) METHODS OF MAKING AND USING SKIN DERIVED STEM CELLS
HK1079789A1 (zh) 血管靜態毒性試劑及其使用方法
HK1109062A1 (en) Compositions and methods of use for treatment of mammalian diseases
EP1549756A4 (en) RECOMBINANT MUTANTS OF RHABDOVIRUS AND METHODS OF USE
EP1765085A4 (en) COMPOSITIONS WITH FEMALE GERMAN STEM CELLS AND METHOD OF USE THEREOF
AU2003268531A8 (en) Materials and methods for treatment of allergic diseases
EP1699431A4 (en) COMPOSITIONS FOR THE TREATMENT OF EARLIER DISEASES AND APPLICATION PROCEDURES
EP1639086A4 (en) RNA INTERFERASES AND METHODS OF USE
GB2414480B (en) Directed genetic modifications of human stem cells
EP1750734A4 (en) PROCESS FOR THE PREPARATION AND USE OF FIBRINOLYTIC ENZYMES FOR THE TREATMENT OF DISEASES
HK1131882A1 (en) Educated nkt cells and their uses in the treatment of immune-related disorders
PL371281A1 (en) Methods and compositions for the treatment of eye diseases
ZA200509752B (en) Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
EP1624786A4 (en) METHOD FOR THE TREATMENT AND PREVENTION OF ILLNESSES OF BIOLOGICAL CHANNELS
EP1682171A4 (en) COMPOSITIONS AND METHODS OF TREATING NEUROLOGICAL ILLNESSES
GB0324523D0 (en) Compositions and methods of treatment
EP1601348A4 (en) Compositions and methods with improved therapeutic activity
AU2003295902A8 (en) Methods of therapy and diagnosis using targeting of cells that express p2y10
EP1483407A4 (en) THERAPY AND DIAGNOSTIC PROCEDURES
AU2003302271A8 (en) Methods of treating and/or preventing autoimmune diseases